Effect of Switching Systemic Treatment After Stereotactic Radiosurgery for Oligoprogressive, Metastatic Renal Cell Carcinoma.

Effect of Switching Systemic Treatment After Stereotactic Radiosurgery for Oligoprogressive, Metastatic Renal Cell Carcinoma. Clin Genitourin Cancer. 2018 10; 16(5):413-419.e1.

View in: PubMed

subject areas

Adult
Aged
Antineoplastic Agents
Brain Neoplasms
Carcinoma, Renal Cell
Cohort Studies
Disease Progression
Female
Humans
Kidney Neoplasms
Male
Middle Aged
Precision Medicine
Radiosurgery
Spinal Neoplasms
Survival Analysis
Treatment Outcome

authors with profiles

Aditya Juloori